BNVIBiologie Neurovasculaire Intégrée (French: Neurovascular Integrated Biology)
References in periodicals archive ?
31 August 2010 - US-based drug development company Bionovo Inc (NASDAQ: BNVI) announced today that it has received positive guidance from the US Food and Drug Administration (FDA) regarding the company's Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate Menerba.
6 January 2010 - US pharmaceutical company Bionovo Inc (NASDAQ: BNVI) said today it has appointed Marco Gambacciani to its medical advisory board.
NASDAQ is expected to append a "D" to the company's ticker symbol to indicate the completion of the reverse split and the ticker symbol will revert to "BNVI" following effectiveness of the reverse split after a 20 trading-day period.